- Home
- TWIN vs FENC Comparison
TWIN vs FENC Comparison
Compare TWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- FENC
- Stock Information
- Founded
- TWIN 1918
- FENC 1996
- Country
- TWIN United States
- FENC United States
- Employees
- TWIN N/A
- FENC N/A
- Industry
- TWIN Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWIN Industrials
- FENC Health Care
- Exchange
- TWIN Nasdaq
- FENC Nasdaq
- Market Cap
- TWIN 152.3M
- FENC 156.9M
- IPO Year
- TWIN N/A
- FENC 2001
- Fundamental
- Price
- TWIN $11.47
- FENC $5.74
- Analyst Decision
- TWIN
- FENC Strong Buy
- Analyst Count
- TWIN 0
- FENC 2
- Target Price
- TWIN N/A
- FENC $14.00
- AVG Volume (30 Days)
- TWIN 22.9K
- FENC 68.3K
- Earning Date
- TWIN 02-05-2025
- FENC 11-07-2024
- Dividend Yield
- TWIN 1.41%
- FENC N/A
- EPS Growth
- TWIN N/A
- FENC N/A
- EPS
- TWIN 0.68
- FENC N/A
- Revenue
- TWIN $304,470,000.00
- FENC $49,348,000.00
- Revenue This Year
- TWIN N/A
- FENC $170.43
- Revenue Next Year
- TWIN N/A
- FENC $6.70
- P/E Ratio
- TWIN $16.60
- FENC N/A
- Revenue Growth
- TWIN 6.98
- FENC 278.09
- 52 Week Low
- TWIN $10.22
- FENC $3.96
- 52 Week High
- TWIN $18.00
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- TWIN 49.71
- FENC 46.75
- Support Level
- TWIN $10.98
- FENC $5.47
- Resistance Level
- TWIN $11.46
- FENC $6.19
- Average True Range (ATR)
- TWIN 0.41
- FENC 0.25
- MACD
- TWIN 0.02
- FENC -0.09
- Stochastic Oscillator
- TWIN 67.57
- FENC 24.77
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.